A multicenter phase III randomized, controlled study of Theratope vaccine for metastatic breast cancer

Trial Profile

A multicenter phase III randomized, controlled study of Theratope vaccine for metastatic breast cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2013

At a glance

  • Drugs Cancer vaccine Theratope (Primary) ; Cyclophosphamide; Keyhole limpet haemocyanin
  • Indications Advanced breast cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Aug 2011 Results published in the Oncologist.
    • 10 Dec 2008 Company name changed from Biomira to Oncothyreon, and completion date added from ClinicalTrials.gov record.
    • 10 Dec 2008 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top